[1]
|
Wang, L.N., Zhang, S., Ma, J., Ni, J., Wang, J.Y., Li, X.H., Mu, Z.L., Han, W., He, G.T., Ma, L., Shah, J., Shah, J. and Jiao, F.Y. (2021) Kawasaki Disease-Management Strategies Given Symptoms Overlap to COVID-19: A Review. Jour-nal of Nepal Medical Association, 59, 417-424. https://doi.org/10.31729/jnma.5698
|
[2]
|
Yale, S.H., Tekiner, H. and Yale, E.S. (2022) Tomisaku Kawasaki and Kawasaki Disease. Child’s Nervous System, 38, 233-235. https://doi.org/10.1007/s00381-020-04784-3
|
[3]
|
Alphonse, M.P., Duong, T.T., Tam, S. and Yeung, R.S.M. (2023) Mercury Increases IL-1beta and IL-18 Secretion and Intensifies Coronary Arteritis in an Animal Model of Kawa-saki Disease. Frontiers in Immunology, 14, Article 1126154.
https://doi.org/10.3389/fimmu.2023.1126154
|
[4]
|
Agarwal, S. and Agrawal, D.K. (2017) Kawasaki Disease: Eti-opathogenesis and Novel Treatment Strategies. Expert Review of Clinical Immunology, 13, 247-258. https://doi.org/10.1080/1744666X.2017.1232165
|
[5]
|
Banday, A.Z., Arul, A., Vignesh, P., et al. (2021) Kawasaki Disease and Influenza-New Lessons from Old Associations. Clinical Rheumatology, 40, 2991-2999. https://doi.org/10.1007/s10067-020-05534-1
|
[6]
|
Huerta, B.S. and Sanchez, A.A. (2022) Biomarkers in Kawasaki Disease. Biomarkers in Medicine, 51-56.
|
[7]
|
Onouchi, Y., Ozaki, K., Burns, J.C., et al. (2012) A Genome-Wide As-sociation Study Identifies Three New Risk Loci for Kawasaki Disease. Nature Genetics, 44, 517-521. https://doi.org/10.1038/ng.2220
|
[8]
|
Wu, R., Ohara, R.A., Jo, S., et al. (2022) Mechanisms of CD40-Dependent cDC1 Licensing beyond Costimulation. Nature Immunology, 23, 1536-1550. https://doi.org/10.1038/s41590-022-01324-w
|
[9]
|
Rife, E. and Gedalia, A. (2020) Kawasaki Disease: An Update. Current Rheumatology Reports, 22, Article No. 75.
https://doi.org/10.1007/s11926-020-00941-4
|
[10]
|
Butters, C., Curtis, N. and Burgner, D.P. (2020) Kawasaki Dis-ease Fact Check: Myths, Misconceptions and Mysteries. Journal of Paediatrics and Child Health, 56, 1343-1345. https://doi.org/10.1111/jpc.15101
|
[11]
|
Jaggi, P., Kajon, A.E., Mejias, A., et al. (2013) Human Adenovirus Infec-tion in Kawasaki Disease: A Confounding Bystander? Clinical Infectious Diseases, 56, 58-64. https://doi.org/10.1093/cid/cis807
|
[12]
|
Noval, R.M. and Arditi, M. (2020) Kawasaki Disease: Pathophysiology and Insights from Mouse Models. Nature Reviews Rheumatology, 16, 391-405. https://doi.org/10.1038/s41584-020-0426-0
|
[13]
|
Cameron, S.A., White, S.M., Arrollo, D., Shulman, S.T. and Rowley, A.H. (2017) Arterial Immune Protein Expression Demonstrates the Complexity of Immune Responses in Ka-wasaki Disease Arteritis. Clinical and Experimental Immunology, 190, 244-250. https://doi.org/10.1111/cei.13010
|
[14]
|
Kim, K.Y. and Kim, D.S. (2016) Recent Advances in Kawasaki Disease. Yonsei Medical Journal, 57, 15-21.
https://doi.org/10.3349/ymj.2016.57.1.15
|
[15]
|
Cattalini, M., Della, P.S., Zunica, F., et al. (2021) Defining Kawasa-ki Disease and Pediatric Inflammatory Multisystem Syndrome-Temporally Associated to SARS-CoV-2 Infection during SARS-CoV-2 Epidemic in Italy: Results from a National, Multicenter Survey. Pediatric Rheumatology, 19, Article No. 29.
https://doi.org/10.1186/s12969-021-00511-7
|
[16]
|
Galeotti, C., Bayry, J., Kone-Paut, I. and Kaveri S.V., (2010) Kawasaki Disease: Aetiopathogenesis and Therapeutic Utility of Intravenous Immunoglobulin. Autoimmunity Reviews, 9, 441-448.
https://doi.org/10.1016/j.autrev.2009.12.004
|
[17]
|
Alexoudi, I., Kanakis, M., Kapsimali, V. and Vaiopoulos, G. (2011) Kawasaki Disease: Current Aspects on Aetiopathogenesis and Therapeutic Management. Autoimmunity Reviews, 10, 544-547.
https://doi.org/10.1016/j.autrev.2011.04.005
|
[18]
|
Gupta, A. (2023) Role of Inflammasomes in Kawasaki Disease. Indian Journal of Pediatrics, 90, 5-6.
https://doi.org/10.1007/s12098-022-04356-0
|
[19]
|
Wan, F., Wang, H., Wang, M., et al. (2022) Sustained Release of Lactobacillus casei Cell Wall Extract Can Induce a Continuous and Stable IgA Deposition Model. The Journal of Pa-thology, 257, 262-273.
https://doi.org/10.1002/path.5884
|
[20]
|
Yoshida, Y., Banno-Terada, R., Takada, M., et al. (2022) Sivelestat’s Effect on Candida albicans Water-Soluble Fraction-Induced Vasculitis. Pediatrics International, 64, e15153. https://doi.org/10.1111/ped.15153
|
[21]
|
Wan, M., Lin, S., Tan, C., et al. (2023) Effects of Mannoprotein on the Sta-bility and in vitro Digestion of Cyanidin-3- Glucoside. Food Chemistry, 404, Article ID: 134602. https://doi.org/10.1016/j.foodchem.2022.134602
|
[22]
|
Bordea, M.A., Costache, C., Grama, A., et al. (2022) Cyto-kine Cascade in Kawasaki Disease versus Kawasaki-Like Syndrome. Physiological Research, 71, 17-27. https://doi.org/10.33549/physiolres.934672
|
[23]
|
Suganuma, E., Sato, S., Honda, S. and Nakazawa, A. (2020) A Novel Mouse Model of Coronary Stenosis Mimicking Kawasaki Disease Induced by Lactobacillus casei Cell Wall Ex-tract. Experimental Animals, 69, 233-241.
https://doi.org/10.1538/expanim.19-0124
|
[24]
|
Zhang, J., Weng, H., Pei, Q., et al. (2022) The Relationship between TNF-Like Protein 1A and Coronary Artery Aneurysms in Children with Kawasaki Disease. Clinical and Experimental Medicine, 22, 57-63.
https://doi.org/10.1007/s10238-021-00729-5
|
[25]
|
Matundan, H.H., Sin, J., Rivas, M.N., et al. (2019) Myocardial Fibrosis after Adrenergic Stimulation as a Long-Term Sequela in a Mouse Model of Kawasaki Disease Vasculitis. JCI Insight, 4, e126279.
https://doi.org/10.1172/jci.insight.126279
|
[26]
|
Gorelik, M., Chung, S.A., Ardalan, K., et al. (2022) 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Care & Research, 74, 538-548.
https://doi.org/10.1002/acr.24838
|
[27]
|
Lam, J.Y., Shimizu, C., Tremoulet, A.H., et al. (2022) A Machine-Learning Algorithm for Diagnosis of Multisystem Inflammatory Syndrome in Children and Kawasaki Disease in the USA: A Ret-rospective Model Development and Validation Study. The Lancet Digital Health, 4, e717-e726. https://doi.org/10.1016/S2589-7500(22)00149-2
|
[28]
|
Shi, Z., Yin, Y., Li, C., et al. (2021) Lipocalin-2-Induced Proliferative Endoplasmic Reticulum Stress Participates in Kawasaki Disease-Related Pulmonary Arterial Abnormalities. Science China Life Sciences, 64, 1000-1012.
https://doi.org/10.1007/s11427-019-1772-8
|
[29]
|
Murata, H. (1979) Experimental Candida-Induced Arteritis in Mice. Relation to Arteritis in the Mucocutaneous Lymph Node Syndrome. Microbiology and Immunology, 23, 825-831. https://doi.org/10.1111/j.1348-0421.1979.tb02815.x
|
[30]
|
Sato, W., Yokouchi, Y., Oharaseki, T., Asakawa, N. and Takahashi, K. (2021) The Pathology of Kawasaki Disease Aortitis: A Study of 37 Cases. Cardiovascular Pathology, 51, Article ID: 107303.
https://doi.org/10.1016/j.carpath.2020.107303
|
[31]
|
Yokouchi, Y., Oharaseki, T., Enomoto, Y., et al. (2019) Ex-pression of Tenascin C in Cardiovascular Lesions of Kawasaki Disease. Cardiovascular Pathology, 38, 25-30. https://doi.org/10.1016/j.carpath.2018.10.005
|
[32]
|
Ito, F., Oharaseki, T., Tsukui, D., et al. (2022) Beneficial Effects of Anti-Apolipoprotein A-2 on an Animal Model for Coronary Arteritis in Kawasaki Disease. Pediatric Rheumatology, 20, Article No. 119.
https://doi.org/10.1186/s12969-022-00783-7
|
[33]
|
Xu, S., Chen, M. and Weng, J. (2020) COVID-19 and Kawasaki Disease in Children. Pharmacological Research, 159, Article ID: 104951. https://doi.org/10.1016/j.phrs.2020.104951
|
[34]
|
Yanai, C., Tanaka, H., Miura, N.N., et al. (2020) Coronary Vas-culitis Induced in Mice by the Cell Wall Mannoprotein of Candida krusei. Biological and Pharmaceutical Bulletin, 43, 848-858. https://doi.org/10.1248/bpb.b19-01060
|
[35]
|
Nakamura, T., Yamamura, J., Sato, H., et al. (2007) Vascu-litis Induced by Immunization with Bacillus Calmette-Guerin Followed by Atypical Mycobacterium Antigen: A New Mouse Model for Kawasaki Disease. FEMS Immunology & Medical Microbiology, 49, 391-397. https://doi.org/10.1111/j.1574-695X.2007.00217.x
|
[36]
|
Delvechio, M., Alves, J.V., Saiyid, A.Z., et al. (2023) Progression of Vascular Function and Blood Pressure in a Mouse Model of Kawasaki Disease. Shock, 59, 74-81. https://doi.org/10.1097/SHK.0000000000002026
|
[37]
|
Chun, J.K., Jeon, B.Y., Kang, D.W., et al. (2011) Bacille Calmette Guerin (BCG) Can Induce Kawasaki Disease-Like Features in Programmed Death-1 (PD-1) Gene Knockout Mice. Clinical and Experimental Rheumatology, 29, 743-750.
|
[38]
|
Nishio, H., Kanno, S., Onoyama, S., et al. (2011) Nod1 Ligands Induce Site-Specific Vascular Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 1093-1099. https://doi.org/10.1161/ATVBAHA.110.216325
|
[39]
|
Natarajan, R.K., Bhoopalan, S.V., Cross, C., Shah, R. and Rothman, A. (2023) Novel Score to Predict Immunoglobulin Resistance in Kawasaki Disease. Pediatric Cardiology, 44, 1546-1551. https://doi.org/10.1007/s00246-023-03175-0
|
[40]
|
Dou, J., Li, H., Sun, L., et al. (2013) Histopathological and Ultrastructural Examinations of Rabbit Coronary Artery Vasculitis Caused by Bovine Serum Albumin: An Animal Model of Kawasaki Disease. Ultrastructural Pathology, 37, 139-145. https://doi.org/10.3109/01913123.2012.750409
|
[41]
|
Philip, S., Jindal, A. and Krishna, K.R. (2023) An Update on Understanding the Pathophysiology in Kawasaki Disease: Possible Role of Immune Complexes in Coronary Artery Le-sion Revisited. International Journal of Rheumatic Diseases, 26, 1453-1463. https://doi.org/10.1111/1756-185X.14816
|